Inhibitors of Dipeptidyl Peptidase IV and Aminopeptidase N Target Major Pathogenetic Steps in Acne Initiation
Open Access
- 1 May 2007
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 127 (5) , 1042-1051
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Distinct Strains of Propionibacterium acnes Induce Selective Human β-Defensin-2 and Interleukin-8 Expression in Human Keratinocytes Through Toll-Like ReceptorsJournal of Investigative Dermatology, 2005
- Inflammatory Events Are Involved in Acne Lesion InitiationJournal of Investigative Dermatology, 2003
- Current Concepts of the Pathogenesis of AcneDrugs, 2003
- Analysis of common side effects of isotretinoinJournal of the American Academy of Dermatology, 2001
- Inhibition of Alanyl-Aminopeptidase Suppresses the Activation-Dependent Induction of Glycogen Synthase Kinase-3β (GSK-3β) in Human T CellsBiochemical and Biophysical Research Communications, 2000
- Establishment and Characterization of an Immortalized Human Sebaceous Gland Cell Line (SZ95)1Journal of Investigative Dermatology, 1999
- Cd26/Dipeptidyl Peptidase IV in ContextJournal of Experimental Medicine, 1999
- CD13—not just a marker in leukemia typingImmunology Today, 1999
- Suppression of arthritis by the inhibitors of dipeptidyl peptidase IVInternational Journal of Immunopharmacology, 1997
- Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseasesBritish Journal of Dermatology, 1996